Cargando…
To charge or not to charge: reducing patient no-show
BACKGROUND: In order to reduce patient no-show, the Israeli government is promoting legislation that will allow Health Plans to require a co-payment from patients when reserving an appointment. It is hoped that this will create an incentive for patients to cancel in advance rather than simply not sh...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408071/ https://www.ncbi.nlm.nih.gov/pubmed/37550725 http://dx.doi.org/10.1186/s13584-023-00575-8 |
_version_ | 1785086104425201664 |
---|---|
author | Leibner, Gideon Brammli-Greenberg, Shuli Mendlovic, Joseph Israeli, Avi |
author_facet | Leibner, Gideon Brammli-Greenberg, Shuli Mendlovic, Joseph Israeli, Avi |
author_sort | Leibner, Gideon |
collection | PubMed |
description | BACKGROUND: In order to reduce patient no-show, the Israeli government is promoting legislation that will allow Health Plans to require a co-payment from patients when reserving an appointment. It is hoped that this will create an incentive for patients to cancel in advance rather than simply not show up. The goal of this policy is to improve patient access to medical care and ensure that healthcare resources are utilized effectively. We explore this phenomenon to support evidence-based decision making on this issue, and to determine whether the proposed legislation is aligned with the findings of previous studies. MAIN BODY: No-show rates vary across countries and healthcare services, with several strategies in place to mitigate the phenomenon. There are three key stakeholders involved: (1) patients, (2) medical staff, and (3) insurers/managed care organizations, each of which is affected differently by no-shows and faces a different set of incentives. The decision whether to impose financial penalties for no-shows should take a number of considerations into account, such as the fine amount, service type, the establishment of an effective fine collection system, the patient’s socioeconomic status, and the potential for exacerbating disparities in healthcare access. The limited research on the impact of fines on no-show rates has produced mixed results. Further investigation is necessary to understand the influence of fine amounts on no-show rates across various healthcare services. Additionally, it is important to evaluate the implications of this proposed legislation on patient behavior, access to healthcare, and potential disparities in access. CONCLUSION: It is anticipated that the proposed legislation will have minimal impact on attendance rates. To achieve meaningful change, efforts should focus on enhancing medical service availability and improving the ease with which appointments can be cancelled or alternatively substantial fines should be imposed. Further research is imperative for determining the most effective way to address the issue of patient no-show and to enhance healthcare system efficiency. |
format | Online Article Text |
id | pubmed-10408071 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104080712023-08-09 To charge or not to charge: reducing patient no-show Leibner, Gideon Brammli-Greenberg, Shuli Mendlovic, Joseph Israeli, Avi Isr J Health Policy Res Integrative Article BACKGROUND: In order to reduce patient no-show, the Israeli government is promoting legislation that will allow Health Plans to require a co-payment from patients when reserving an appointment. It is hoped that this will create an incentive for patients to cancel in advance rather than simply not show up. The goal of this policy is to improve patient access to medical care and ensure that healthcare resources are utilized effectively. We explore this phenomenon to support evidence-based decision making on this issue, and to determine whether the proposed legislation is aligned with the findings of previous studies. MAIN BODY: No-show rates vary across countries and healthcare services, with several strategies in place to mitigate the phenomenon. There are three key stakeholders involved: (1) patients, (2) medical staff, and (3) insurers/managed care organizations, each of which is affected differently by no-shows and faces a different set of incentives. The decision whether to impose financial penalties for no-shows should take a number of considerations into account, such as the fine amount, service type, the establishment of an effective fine collection system, the patient’s socioeconomic status, and the potential for exacerbating disparities in healthcare access. The limited research on the impact of fines on no-show rates has produced mixed results. Further investigation is necessary to understand the influence of fine amounts on no-show rates across various healthcare services. Additionally, it is important to evaluate the implications of this proposed legislation on patient behavior, access to healthcare, and potential disparities in access. CONCLUSION: It is anticipated that the proposed legislation will have minimal impact on attendance rates. To achieve meaningful change, efforts should focus on enhancing medical service availability and improving the ease with which appointments can be cancelled or alternatively substantial fines should be imposed. Further research is imperative for determining the most effective way to address the issue of patient no-show and to enhance healthcare system efficiency. BioMed Central 2023-08-08 /pmc/articles/PMC10408071/ /pubmed/37550725 http://dx.doi.org/10.1186/s13584-023-00575-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Integrative Article Leibner, Gideon Brammli-Greenberg, Shuli Mendlovic, Joseph Israeli, Avi To charge or not to charge: reducing patient no-show |
title | To charge or not to charge: reducing patient no-show |
title_full | To charge or not to charge: reducing patient no-show |
title_fullStr | To charge or not to charge: reducing patient no-show |
title_full_unstemmed | To charge or not to charge: reducing patient no-show |
title_short | To charge or not to charge: reducing patient no-show |
title_sort | to charge or not to charge: reducing patient no-show |
topic | Integrative Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408071/ https://www.ncbi.nlm.nih.gov/pubmed/37550725 http://dx.doi.org/10.1186/s13584-023-00575-8 |
work_keys_str_mv | AT leibnergideon tochargeornottochargereducingpatientnoshow AT brammligreenbergshuli tochargeornottochargereducingpatientnoshow AT mendlovicjoseph tochargeornottochargereducingpatientnoshow AT israeliavi tochargeornottochargereducingpatientnoshow |